Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Martin Šimkovič

Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma.

scientific article

Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies

scientific article published on 17 December 2017

Assessment of selected markers of apoptosis and angiogenesis in chronic lymphocytic leukemia

scientific article published on September 1, 2013

Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice

scientific article

Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders

scientific article published on 09 January 2019

Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia

scientific article published on 8 December 2015

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

scientific article published on 03 December 2018

Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry

scientific article published on 06 September 2018

Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance

scientific article published on 13 September 2018

Practical approach to management of chronic lymphocytic leukemia

scientific article published on 8 December 2015

Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study

scientific article published on 26 September 2019

Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia

scientific article published in 2014

Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab

scientific article published on 15 February 2019

RCD Chemoimmunotherapy For Relapsed Chronic Lymphocytic Leukaemia

scientific article published on 06 October 2020

Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia.

scientific article

Rituximab infusion-related toxicity in patients with chronic lymphocytic leukemia

scientific article published on January 2015

The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab

scientific article published on 27 April 2013

Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: Report of two cases

scientific article published on 22 August 2011

Treatment of Multifocal Multisystem BRAF Positive Langerhans Cell Histiocytosis with Cladribine, Surgery and Allogenic Stem Cell Transplantation

scientific article published on 01 January 2017

Venous thromboembolism in patients with chronic lymphocytic leukemia.

scientific article

Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion

scientific article published on 13 October 2020

Chronická lymfocytární leukemie: informace pro pacienty a jejich blízké

book edition published in 2023

Paulina is supported by:

About Paulina

Help